As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis
First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer
FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer
FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma